Considerations for animal models of blast-related traumatic brain injury and chronic traumatic encephalopathy

被引:45
|
作者
Goldstein, Lee E. [1 ,2 ,3 ]
McKee, Ann C. [2 ,3 ,4 ]
Stanton, Patric K. [5 ,6 ,7 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Coll Engn, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA
[4] VA Boston Healthcare Syst, US Dept Vet Affairs, Boston, MA 02130 USA
[5] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA
[6] New York Med Coll, Dept Cell Biol, Valhalla, NY 10595 USA
[7] New York Med Coll, Dept Anat, Valhalla, NY 10595 USA
关键词
HIGH EXPLOSIVES; APOLIPOPROTEIN-E; GENETIC-FACTORS; WAR VETERAN; BIOMARKERS; IRAQ; OVERPRESSURE; STATEMENT; EXPOSURE; US;
D O I
10.1186/s13195-014-0064-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The association of military blast exposure and brain injury was first appreciated in World War I as commotio cerebri, and later as shell shock. Similar injuries sustained in modern military conflicts are now classified as mild traumatic brain injury (TBI). Recent research has yielded new insights into the mechanisms by which blast exposure leads to acute brain injury and chronic sequelae, including postconcussive syndrome, post-traumatic stress disorder, post-traumatic headache, and chronic traumatic encephalopathy, a tau protein neurodegenerative disease. Impediments to delivery of effective medical care for individuals affected by blast-related TBI include: poor insight into the heterogeneity of neurological insults induced by blast exposure; limited understanding of the mechanisms by which blast exposure injures the brain and triggers sequelae; failure to appreciate interactive injuries that affect frontal lobe function, pituitary regulation, and neurovegetative homeostasis; unknown influence of genetic risk factors, prior trauma, and comorbidities; absence of validated diagnostic criteria and clinical nosology that differentiate clinical endophenotypes; and lack of empirical evidence to guide medical management and therapeutic intervention. While clinicopathological analysis can provide evidence of correlative association, experimental use of animal models remains the primary tool for establishing causal mechanisms of disease. However, the TBI field is confronted by a welter of animal models with varying clinical relevance, thereby impeding scientific coherence and hindering translational progress. Animal models of blast TBI will be far more translationally useful if experimental emphasis focuses on accurate reproduction of clinically relevant endpoints (output) rather than scaled replication of idealized blast shockwaves (input). The utility of an animal model is dependent on the degree to which the model recapitulates pathophysiological mechanisms, neuropathological features, and neurological sequelae observed in the corresponding human disorder. Understanding the purpose of an animal model and the criteria by which experimental results derived from the model are validated are critical components for useful animal modeling. Animal models that reliably demonstrate clinically relevant endpoints will expedite development of new treatments, diagnostics, preventive measures, and rehabilitative strategies for individuals affected by blast TBI and its aftermath.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Auditory and vestibular dysfunction associated with blast-related traumatic brain injury
    Fausti, Stephen A.
    Wilmington, Debra J.
    Gallun, Frederick J.
    Myers, Paula J.
    Henry, James A.
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2009, 46 (06): : 797 - 809
  • [22] Neuronal DNA Methylation Profiling of Blast-Related Traumatic Brain Injury
    Haghighi, Fatemeh
    Ge, Yongchao
    Chen, Sean
    Xin, Yurong
    Umali, Michelle U.
    De Gasperi, Rita
    Sosa, Miguel A. Gama
    Ahlers, Stephen T.
    Elder, Gregory A.
    JOURNAL OF NEUROTRAUMA, 2015, 32 (16) : 1200 - 1209
  • [23] The role of PET neuroimaging in blast-related traumatic brain injury (TBI)
    Selwyn, Reed
    Tang, Haiying
    Byrnes, Kimberly
    Hinds, Sidney
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [24] Prevalence and Characteristics of Chronic Pituitary Dysfunction after Blast-related Mild Traumatic Brain Injury
    Wilkinson, Charles W.
    Peskind, Elaine R.
    Colasurdo, Elizabeth A.
    Pagulayan, Kathleen F.
    Shofer, Jane B.
    BRAIN INJURY, 2012, 26 (4-5) : 732 - 732
  • [25] Blast-Related Mild Traumatic Brain Injury: Mechanisms of Injury and Impact on Clinical Care
    Elder, Gregory A.
    Cristian, Adrian
    MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (02): : 111 - 118
  • [26] The nature of white matter abnormalities in blast-related mild traumatic brain injury
    Hayes, Jasmeet P.
    Miller, Danielle R.
    Lafleche, Ginette
    Salat, David H.
    Verfaellie, Mieke
    NEUROIMAGE-CLINICAL, 2015, 8 : 148 - 156
  • [27] Sex as a Biological Variable in Preclinical Modeling of Blast-Related Traumatic Brain Injury
    McCabe, Joseph T.
    Tucker, Laura B.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [28] Visual dysfunction following blast-related traumatic brain injury from the battlefield
    Dougherty, Amber L.
    MacGregor, Andrew J.
    Han, Peggy P.
    Heltemes, Kevin J.
    Galarneau, Michael R.
    BRAIN INJURY, 2011, 25 (01) : 8 - 13
  • [29] Evidence of Central and Peripheral Vestibular Pathology in Blast-Related Traumatic Brain Injury
    Scherer, Matthew R.
    Burrows, Holly
    Pinto, Robin
    Littlefield, Philip
    French, Louis M.
    Tarbett, Aaron K.
    Schubert, Michael C.
    OTOLOGY & NEUROTOLOGY, 2011, 32 (04) : 571 - 580
  • [30] Trends in Symptom Reporting Following Blast-Related Mild Traumatic Brain Injury
    MacGregor, A.
    Watt, D.
    Puente, A.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (06) : 572 - 572